IntroductionRheumatoid arthritis (RA) is a common disease that requires patient self-management with chronic medications. Adherence rates for RA medications are suboptimal. This study explores medication adherence and self-efficacy behaviors among RA patients.MethodsWe conducted a qualitative study comprising focus groups and individual interviews. Nineteen participants were recruited and screened to participate in three 90-minute focus groups (n = 13) and six 60-minute individual interviews. We created and maintained a codebook to analyze data. Interviews were analyzed by using NViVo qualitative analysis software.ResultsKey points in participant interviews were 1) self-efficacy as influenced by the ability to establish routines, and having...
Laura-Alexandra Anghel,1,* Andreea Maria Farcaş,2,* Radu Nicolae Oprean1,* 1Department of Analytica...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...
OBJECTIVES: To investigate levels of self-reported adherence to biologic treatment and establish the...
In this study we examine which factors are related to compliance with medication in patients sufferi...
Adherence to medication in patients with rheumatoid arthritis is low, varying from 30 to 80%. Improv...
Medication nonadherence is prevalent among patients with chronic diseases. Previous research focused...
Adherence to medication in patients with rheumatoid arthritis is low, varying from 30 to 80%. Improv...
Sharan K Rai,1 Alyssa Howren,1,2 Elizabeth S Wilcox,3 Anne F Townsend,1,4 Carlo A Marra,1,5 J Antoni...
Item does not contain fulltextAdherence to medication in patients with rheumatoid arthritis is low, ...
Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease causing inflammation of the s...
Low adherence to the prescribed treatments is significantly prevalent in clinical practice, especial...
Objective: Rheumatoid arthritis (RA) is a common disease affecting about 5 in 1,000 people in Malays...
Aim of the study. Evaluation of treatment adherence in patients with rheumatoid arthritis (RA) and c...
OBJECTIVES: We have developed an instrument that provides the physician structured information about...
Laura-Alexandra Anghel,1,* Andreea Maria Farcaş,2,* Radu Nicolae Oprean1,* 1Department of Analytica...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...
OBJECTIVES: To investigate levels of self-reported adherence to biologic treatment and establish the...
In this study we examine which factors are related to compliance with medication in patients sufferi...
Adherence to medication in patients with rheumatoid arthritis is low, varying from 30 to 80%. Improv...
Medication nonadherence is prevalent among patients with chronic diseases. Previous research focused...
Adherence to medication in patients with rheumatoid arthritis is low, varying from 30 to 80%. Improv...
Sharan K Rai,1 Alyssa Howren,1,2 Elizabeth S Wilcox,3 Anne F Townsend,1,4 Carlo A Marra,1,5 J Antoni...
Item does not contain fulltextAdherence to medication in patients with rheumatoid arthritis is low, ...
Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease causing inflammation of the s...
Low adherence to the prescribed treatments is significantly prevalent in clinical practice, especial...
Objective: Rheumatoid arthritis (RA) is a common disease affecting about 5 in 1,000 people in Malays...
Aim of the study. Evaluation of treatment adherence in patients with rheumatoid arthritis (RA) and c...
OBJECTIVES: We have developed an instrument that provides the physician structured information about...
Laura-Alexandra Anghel,1,* Andreea Maria Farcaş,2,* Radu Nicolae Oprean1,* 1Department of Analytica...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...
Background: Adherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid...